Avacta Share Discussion Threads

[1347] 28/2/2024 20:51

You mean like a dead cat bounce?

[tomavery19] 28/2/2024 18:50

I may buy some purely for a bounce trade that is all no interest holding long termBut it may not bounce it could drop well below 50p first

[atmysignal] 28/2/2024 18:29

The hate and anger here is understandable But this will bounce hard

[atmysignal] 28/2/2024 18:28

Mega bounce tomorrow 13% short need to close

[bonzo] 28/2/2024 18:13

The technology IS that great...

[fieldhouse] 28/2/2024 18:07

owf,
The trials were for safety with patients that had been heavily treated with dox and were terminal.The small sample that responded was a bonus and hence the two weekly dosing.
I think you are being unduly negative and are obsessed with Arisaph withdrall

I also suspect that the fund raise was forced on the company by the US to ensure funds were in place to complete the next complete phase to the end of 2025.

Still everything to play for but confidence severely dented

Rather pi----of of, but wiser

[bspgamer] 28/2/2024 17:53

Remember silence therapeutics, used to be pence on the AIM now $25 on NASDAQ. The same is coming here, patience is a virtue

[jason29] 28/2/2024 17:51

Thankfully only have a smallish (Still painful) holding in here. I'm not convinced throwing good money after bad is the right way to go, but would be happy to be convinced otherwise? As someone mentioned, if the Technology was that great, someone would have been all over them before now. Win some and lose some I guess.

[ohwhatfun] 28/2/2024 17:51

Yes some very sobering comments

Not the holy grail, others in the same game (dox prodrug) that Avacta (assuming success) believe that they can compete with.

Hardly surprising that companies are not interested when the higher dose levels produced hardly any response rates (ORR) out of 40 patients.

It’s very poor v Dox trials, points many have raised repeatedly.

It may be why Arisaph dumped it.
It really does not look good.

[loglorry1] 28/2/2024 17:43

Hold on a moment @tickboo. Surely if you believe you should just give them more money. The lower the price the better as it allows you to accumulate more shares before the eventual monster pay day when AVA6K comes in.

It might be a bit uncomfortable but if you still have faith you should buy more cheap.

Personally I never believed Smithy but I do believe there are believers.

[wilmer100] 28/2/2024 17:37

I had very optimistic hopes for this company and its technology.Now I think it's a dog of a company. Obviously big pharma are not interested and to have to raise money at such a low price indicates to me that this is now a super high risk investment. If the management can further prove their platform technology then this could be an extremely high reward but I now have doubts.It was good to fantasize for a long while, that this could be a game changer. Nevermind.

[hamidahamida] 28/2/2024 17:25

Quarterly loan payments dilution Unbelievable

[pwhite73] 28/2/2024 17:23

When all is said and done the root cause of all of this is the failure to prove the efficacy of AVA6000. This is the sole reason it was never subject to peer review. Even the current Phase I results on patient numbers alone is insufficient to warrant the expenditure of moving it to Phase II.

If AVA6000 even remotely proved efficacy institutions and larger biotechs would be falling over themselves to take a stake in the company.

[amanitaangelicus] 28/2/2024 17:21

Tick ...at least you.re being honest ...hold...you might get back to 95p with a gd wind.

[ohwhatfun] 28/2/2024 17:14

Tick

Sometimes posters are not short, they are just warning about the market behaviour that typifies pre fund raises.

If you check posts you will see fund raises (and insider knowledge of them) typically go on for a minimum of 2 weeks.

They crash it during the raise then heavily discount it.

All done of course under NDAs where the market makers would be oblivious.

Now ask them for details of MMs short that are participating in the raise to square up their books.

Warnings too about Myles and his pump could walk straight into a big discounted raise causing losses for buyers.

And here we are…..

Don’t trust him.

[pwhite73] 28/2/2024 17:06

Still trying to pump AVA6000 to justify their existence now that diagnostic division is being dumped.

Incidentally the diagnostic division was bought in the wake of Covid. Covid is now over so the diagnostic division serves no purpose at all.

50p gives a market cap of £144 million. Still about £100 million over valued.

[loglorry1] 28/2/2024 17:02

Ouch - at least retail mugs get a chance to throw good money after bad at 50p!

[countbasie1] 28/2/2024 17:00

Or to keep the lights on and pay salaries

[fieldhouse] 28/2/2024 16:56

Raising £20 million,

Enough to show validity of AVA6000 !!

Why were PI's denied extra shares at 95p with last raise.

We need detailed explanations

[1347] 28/2/2024 16:54

It's gets worse. Having epically failed to get any Affimer test to market for more than a few weeks and having taken on a large payday loan so they can buy a company to cover that up now they have to flog it shortly afterwards:

Avacta is also actively exploring routes to divest its Diagnostics division in a manner which maximises value for shareholders.

Another absolute debacle bought to you by Smiffy. I reckon this will go sub 50p now.

[1347] 28/2/2024 16:50

Oh and so what price will the next death spiral loan conversion be at? Answers on a post card to: The Wetherby Waffler, C/O Avacta Group Plc.

[beatme1] 28/2/2024 16:48

Avct is done they need more cash for more studies never ending story

[ohwhatfun] 28/2/2024 16:48

Well the steep drop told what was coming, raise in play market killed it.

Good old Myles, pump tweet PIs bought in the high 80’s Fomo game, disgraceful.

[1347] 28/2/2024 16:47

As expected, their Platforms are so good and AVA6000 is such a block buster that they have to gift the shares away at a huge discount. Smiffs done you up like a kipper again, just like he did with the LFT debacle.